Drugs / CM9241GRU
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06577077 | Sep 2024 → Aug 2025 overdue | perennial allergic rhinitis | Ache Laboratorios Farmaceuticos S.A. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CM9241GRU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06577077 ↗ |